The other 6 indications, idiopathic short stature, small for gestational age, Turner syndrome, SHOX gene haploinsufficiency, Noonan syndrome, and chronic renal insufficiency, do not target GH deficiency and instead aim to augment height by supplementing endogenous GH production [1]. The gene discussed is GH1; the disease is Turner syndrome.